New options in breast tumor therapy

Breast tumors, both cancerous and non-cancerous, are one of the most serious health problems facing women today. Early detection is the most powerful tool in combating this problem. Coupled with early detection is the early treatment of tumors or "lumps" found in the breast.

Now women have a new option to treat benign lesions - Novilase^®, a minimally-invasive alternative to surgical lumpectomy.

Fibroadenomas are the most common type of solid breast tumor - affecting 10% of all women. Whether discovered through a self-breast examination or routine mammogram, many women request surgical excision of the fibroadenoma, after consultation with their physician.

Novian Health recently received FDA clearance for Novilase, an image-guided laser ablation device for the treatment of benign breast tumors. Novian Health is planning a clinical trial to obtain FDA clearance of Novilase for malignant breast tumors.

For additional information about the Novilase ABLATE patient registry program, click here.